# @fixelinstitute on Facebook

- **Type:** Image
- **Original URL:** https://www.facebook.com/1275465578125102/posts/840457998292531
- **Gondola URL:** https://gondola.cc/posts/64720738-fixelinstitute-facebook
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/f0cfca2d04.jpg
- **Posted:** 2024-09-29T22:00:42.000+00:00
- **Account Owner:** Grace Huff (@GraceHuff3) — https://gondola.cc/GraceHuff3

## Caption

Fixel’s neurologists and researchers are diving into groundbreaking territory with new brain targets for Deep Brain Stimulation (DBS) in dystonia treatment. While DBS is FDA-approved for targeting the subthalamic nucleus and globus pallidus internus, outcomes can vary widely between patients. This has led researchers to explore alternative targets, focusing on the basal ganglia-thalamo-cortical network and the cerebellum’s role in motor dysfunction. Emerging evidence from pre-clinical and clinical studies suggests novel targets like the cerebellum and thalamus may offer more consistent, effective results in managing dystonia symptoms. #Neurology #DBS #Dystonia #FixelInstitute #Neuroscience #UFHealth

Full Study: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/39308988/

## Stats

- **Views:** 0
- **Likes:** 3
- **Shares:** 0
- **Comments:** 0

## Tags

neuroscience, fixelinstitute, neurology, dystonia, dbs, ufhealth

---
Copyright (c) Gondola